Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients
- 30 September 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (10) , 1739-1743
- https://doi.org/10.1016/0959-8049(96)00188-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Management of Fever in Patients with Cancer and Treatment-Induced NeutropeniaNew England Journal of Medicine, 1993
- Imipenem/CilastatinDrugs, 1992
- Ceftazidime Monotherapy for Empiric Treatment of Febrile Neutropenic Patients: A MetaanalysisThe Journal of Infectious Diseases, 1991
- Antibiotic Therapy for the Febrile Granulocytopenic Cancer Patient: Combination Therapy vs. MonotherapyClinical Infectious Diseases, 1989
- A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and NeutropeniaNew England Journal of Medicine, 1986
- Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancerThe American Journal of Medicine, 1985
- Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopeniaAntimicrobial Agents and Chemotherapy, 1984
- Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patientsJournal of Antimicrobial Chemotherapy, 1983
- A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patientsJournal of Antimicrobial Chemotherapy, 1983
- Three Antibiotic Regimens in the Treatment of Infection in Febrile Granulocytopenic Patients with CancerThe Journal of Infectious Diseases, 1978